scholarly journals Overweight and Obesity in Patients with Congenital Heart Disease: A Systematic Review

Author(s):  
Laura Willinger ◽  
Leon Brudy ◽  
Michael Meyer ◽  
Renate Oberhoffer-Fritz ◽  
Peter Ewert ◽  
...  

Background: Overweight and obesity have become a major public health concern in recent decades, particularly in patients with chronic health conditions like congenital heart disease (CHD). This systematic review elaborates on the prevalence and the longitudinal development of overweight and obesity in children and adults with CHD. Methods: A systematic literature search was conducted in PubMed, Cochrane, and Scopus from January 2010 to December 2020 on overweight and obesity prevalence in children and adults with CHD. Results: Of 30 included studies, 15 studies evaluated 5680 pediatric patients with CHD, 9 studies evaluated 6657 adults with CHD (ACHD) and 6 studies examined 9273 both pediatric patients and ACHD. Fifteen studies received the quality rating “good”, nine studies “fair”, and six studies “poor”. In children with CHD, overweight prevalence was between 9.5–31.5%, and obesity prevalence was between 9.5–26%; in ACHD, overweight prevalence was between 22–53%, and obesity was between 7–26%. The prevalence of overweight and obesity was thereby similar to the general population. Overweight and obesity have been shown to increase with age. Conclusion: The prevalence of overweight and obesity in children and adults with CHD is similar to the general population, demonstrating that the growing obesity pandemic is also affecting the CHD population.

2019 ◽  
Vol 90 (2) ◽  
pp. 102-108
Author(s):  
Francesca Perin ◽  
Carmen Carreras Blesa ◽  
Maria del Mar Rodríguez Vázquez del Rey ◽  
Inmaculada Cobo ◽  
José Maldonado

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Sandra Mari Barbiero ◽  
Caroline D’Azevedo Sica ◽  
Daniela Schneid Schuh ◽  
Claudia Ciceri Cesa ◽  
Rosemary de Oliveira Petkowicz ◽  
...  

2021 ◽  
pp. 1357633X2098405
Author(s):  
Rachel Crawford ◽  
Ciara Hughes ◽  
Sonyia McFadden ◽  
Jacqui Crawford

Objectives This review aimed to present the clinical and health-care outcomes for patients with congenital heart disease (CHD) who use home monitoring technologies. Methods Five databases were systematically searched from inception to November 2020 for quantitative studies in this area. Data were extracted using a pre-formatted data-collection table which included information on participants, interventions, outcome measures and results. Risk of bias was determined using the Cochrane Risk of Bias 2 tool for randomised controlled trials (RCTs), the Newcastle–Ottawa Quality Assessment Scale for cohort studies and the Institute of Health Economics quality appraisal checklist for case-series studies. Data synthesis: Twenty-two studies were included in this systematic review, which included four RCTs, 12 cohort studies and six case-series studies. Seventeen studies reported on mortality rates, with 59% reporting that home monitoring programmes were associated with either a significant reduction or trend for lower mortality and 12% reporting that mortality trended higher. Fourteen studies reported on unplanned readmissions/health-care resource use, with 29% of studies reporting that this outcome was significantly decreased or trended lower with home monitoring and 21% reported an increase. Impact on treatment was reported in 15 studies, with 67% of studies finding that either treatment was undertaken significantly earlier or significantly more interventions were undertaken in the home monitoring groups. Conclusion The use of home monitoring programmes may be beneficial in reducing mortality, enabling earlier and more timely detection and treatment of CHD complication. However, currently, this evidence is limited due to weakness in study designs.


2021 ◽  
Vol 44 (4) ◽  
pp. 526-530
Author(s):  
Hasan Ashkanani ◽  
Idrees Mohiyaldeen ◽  
Hazem ElShenawy ◽  
Muath Alanbaei

Sign in / Sign up

Export Citation Format

Share Document